DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Sato, Takashi ^a,b   Arai, Eri ^a   Kohno, Takashi ^a   Tsuta, Koji ^c   Watanabe, Shun ichi ^c   Soejima, Kenzo ^b   Betsuyaku, Tomoko ^b   Kanai, Yae ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR PROTEIN;

ADCY5 GENE; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; EVX1 GENE; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ASSOCIATION; GFRA1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PDE9A GENE; PRECANCER; RECURRENT CANCER; TBX20 GENE; TRANSCRIPTION REGULATION; TUMOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AZACITIDINE; DNA METHYLATION; DNA PROBES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, NEOPLASM; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER;

EID: 84875434627     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059444     Document Type: Article

References (43)

1. Pao W, Girard N, (2011) New driver mutations in non-small-cell lung cancer. Lancet Oncol 12: 175-180.
2. Greulich H, (2010) The genomics of lung adenocarcinoma: opportunities for targeted therapies. Genes Cancer 1: 1200-1210.
3. Liu P, Morrison C, Wang L, Xiong D, Vedell P, et al. (2012) Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis 33: 1270-1276.
4. Baylin SB, Jones PA, (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 11: 726-734.
5. Kanai Y, (2010) Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci 101: 36-45.
6. Kanai Y, (2008) Alterations of DNA methylation and clinicopathological diversity of human cancers. Pathol Int 58: 544-558.
7. Kanai Y, Hirohashi S, (2007) Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28: 2434-2442.
8. Heller G, Zielinski CC, Zöchbauer-Müller S, (2010) Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev 29: 95-107.
9. Hamilton JP, (2011) Epigenetics: principles and practice. Dig Dis. 29: 130-135.
10. Eguchi K, Kanai Y, Kobayashi K, Hirohashi S, (1997) DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. Cancer Res 57: 4913-4915.
11. Zöchbauer-Müller S, Lam S, Toyooka S, Virmani AK, Toyooka KO, et al. (2003) Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 107: 612-616.
12. Arai E, Chiku S, Mori T, Gotoh M, Nakagawa T, et al. (2012) Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. Carcinogenesis 33: 1487-1493.
13. Arai E, Ushijima S, Fujimoto H, Hosoda F, Shibata T, et al. (2009) Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome. Carcinogenesis 30: 214-221.
14. Arai E, Kanai Y, Ushijima S, Fujimoto H, Mukai K, et al. (2006) Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int J Cancer 119: 288-296.
15. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, et al. (2009) Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 1: 177-200.
16. Selamat SA, Chung BS, Girard L, Zhang W, Zhang Y, et al. (2012) Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res 22: 1197-1211.
17. Lockwood WW, Wilson IM, Coe BP, Chari R, Pikor LA, et al. (2012) Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development. PLoS One 7: e37775.
18. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (2004) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press. pp. 35-44.
19. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning. A Laboratory Manual (2nd ed). Cold spring Harbor: Cold Spring Harbor Laboratory Press. pp. E3-E4.
20. Yan L, Vatner DE, O'Connor JP, Ivessa A, Ge H, et al. (2007) Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 130: 247-258.
21. Okumura S, Vatner DE, Kurotani R, Bai Y, Gao S, et al. (2007) Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation 116: 1776-1783.
22. Poliak S, Salomon D, Elhanany H, Sabanay H, Kiernan B, et al. (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162: 1149-1160.
23. Bralten LB, Gravendeel AM, Kloosterhof NK, Sacchetti A, Vrijenhoek T, et al. (2010) The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma. Oncogene 29: 6138-6148.
24. Briata P, Van De Werken R, Airoldi I, Ilengo C, Di Blas E, et al. (1995) Transcriptional repression by the human homeobox protein EVX1 in transfected mammalian cells. J Biol Chem 270: 27695-27701.
25. Ledda F, Paratcha G, Sandoval-Guzmán T, Ibáñez CF, (2007) GDNF and GFRalpha1 promote formation of neuronal synapses by ligand-induced cell adhesion. Nat Neurosci 10: 293-300.
26. Fisher DA, Smith JF, Pillar JS, St Denis SH, Cheng JB, (1998) Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem 273: 15559-15564.
27. Saravani R, Karami-Tehrani F, Hashemi M, Aghaei M, Edalat R, (2012) Inhibition of phosphodiesterase 9 induces cGMP accumulation and apoptosis in human breast cancer cell lines, MCF-7 and MDA-MB-468. Cell Prolif 45: 199-206.
28. Chakraborty S, Yutzey KE, (2012) Tbx20 regulation of cardiac cell proliferation and lineage specialization during embryonic and fetal development in vivo. Dev Biol 363: 234-246.
29. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, et al. (2011) International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: 244-285.
30. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, et al. (1995) Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75: 2844-2852.
31. Kadara H, Kabbout M, Wistuba II, (2012) Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology 17: 50-65.
32. Kuang SQ, Tong WG, Yang H, Lin W, Lee MK, et al. (2008) Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia 22: 1529-1538.
33. Tong WG, Wierda WG, Lin E, Kuang SQ, Bekele BN, et al. (2010) Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 5: 499-508.
34. Omura N, Li CP, Li A, Hong SM, Walter K, et al. (2008) Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 7: 1146-1156.
35. Truong M, Yang B, Wagner J, Kobayashi Y, Rajamanickam V, et al. (2012) Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. Br J Cancer 107: 100-107.
36. Sinclair PB, Parker H, An Q, Rand V, Ensor H, et al. (2011) Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy. Hum Mol Genet 20: 2591-2602.
37. de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, et al. (2012) An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Clin Cancer Res 18: 2976-2986.
38. Dietrich D, Hasinger O, Liebenberg V, Field JK, Kristiansen G, et al. (2012) DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients. Diagn Mol Pathol 21: 93-104.
39. Wu D, Xiong L, Wu S, Jiang M, Lian G, et al. (2012) TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer. Lung Cancer 76: 106-111.
40. Verri C, Roz L, Conte D, Liloglou T, Livio A, et al. (2009) Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project. Am J Respir Crit Care Med 179: 396-401.
41. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, et al. (2008) DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 358: 1118-1128.
42. Morán A, Fernández-Marcelo T, Carro J, De Juan C, Pascua I, et al. (2012) Methylation profiling in non-small cell lung cancer: clinical implications. Int J Oncol 40: 739-746.
43. Carvalho RH, Haberle V, Hou J, van Gent T, Thongjuea S, et al. (2012) Genome-wide DNA methylation profiling of non-small cell lung carcinomas. Epigenetics Chromatin 5: 9.